Glioblastoma: New ‘Mussel-Inspired’ Patch Targets Cancer Cells After Surgery
Glioblastoma is one of the most aggressive forms of cancer known. Even after surgery to remove the visible tumor in the brain, the disease often returns. This recurrence is due to tumor cells that remain in the surrounding brain tissue, later growing into a new tumor.
The Challenge of Treating Glioblastoma
Researchers at the Catalan Institute of Nanoscience and Nanotechnology have identified a potential approach to target these remaining cells. This method doesn’t rely on additional radiation or harsh medications, but instead utilizes a thin, bioadhesive membrane – a “patch” – inspired by an unexpected source: the mussel.
Tumor cells in glioblastoma don’t grow in a contained manner. They spread among healthy brain cells, making complete surgical removal without causing damage impossible. Post-operative treatments also don’t always reach every cell in the affected area.
The area where the tumor was removed is therefore critical, as it often harbors the cells responsible for future tumor growth. This new method aims to specifically target these harmful cells while sparing important cells nearby, offering new possibilities for treating this aggressive cancer.
Inspired by Nature: The Mussel’s Grip
Mussels are known for their ability to firmly attach to wet surfaces, even in turbulent seas. They achieve this using specific chemical structures that function effectively in moist environments.
Researchers used this principle to create a thin, bioadhesive membrane that adheres well to moist brain tissue. The membrane is applied during surgery and remains in place without the need for extra glue or stitches.
What Happens Next?
The membrane contains chemical compounds that, in this application, both adhere to the surface and have a biological effect. In laboratory and tissue models, the material around remaining glioblastoom cells caused a significant increase in what is known as oxidative stress. This stress disrupts essential processes within the tumor cells, causing them to lose their ability to survive. Healthy brain cells showed a much weaker response to this effect.
This research is still in its early stages and has been conducted in preclinical models. This means it is not yet known if or how this approach will work in patients. Clinical applications are still some time away.
However, the research demonstrates new ways to better utilize the period immediately following surgery. By intervening specifically at the site with the highest risk, researchers hope to reduce the chance of glioblastoma returning in the future.
Frequently Asked Questions
Why is glioblastoma so difficult to treat?
Glioblastoom cells spread between healthy brain cells, making complete surgical removal impossible without causing damage. Post-operative treatments also don’t always reach every cell.
What is the role of the bioadhesive membrane?
The membrane adheres to the brain tissue after surgery and contains chemical compounds that increase oxidative stress in remaining tumor cells, disrupting their ability to survive.
Is this treatment available to patients now?
No, the research is in a preclinical stage and has only been tested in laboratory and tissue models. Clinical applications are still in the future.
What are your thoughts on the potential of bio-inspired solutions in cancer treatment?